0001724521-23-000008.txt : 20230920 0001724521-23-000008.hdr.sgml : 20230920 20230920164746 ACCESSION NUMBER: 0001724521-23-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230918 FILED AS OF DATE: 20230920 DATE AS OF CHANGE: 20230920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nuyten Dimitry SA CENTRAL INDEX KEY: 0001776564 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 231266976 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE STREET 2: C/O ADURO BIOTECH, INC. CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 wk-form4_1695242857.xml FORM 4 X0508 4 2023-09-18 0 0001724521 Arcus Biosciences, Inc. RCUS 0001776564 Nuyten Dimitry SA C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 Chief Medical Officer 1 Common Stock 2023-09-18 4 D 0 3708 20.40 D 73591 D Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person. Includes 799 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan. /s/ Carolyn Tang, Attorney-in-Fact 2023-09-20